USFDA issues six observations for Granules India Gagillapur facility Ruchika Sharma7 Sept 2024 2:44 PM ISTHyderabad: Granules India Limited, has announced that the US Food and Drug Administration (USFDA) has concluded inspection at the Company's...
Granules India bags USFDA okay for Glycopyrrolate Oral Solution Ruchika Sharma20 Aug 2024 3:39 PM ISTHyderabad: Granules India has announced that the U.S. Food and Drug Administration (FDA) has approved its Abbreviated New Drug Application (ANDA)...
Major depressive disorder drug: USFDA nod to Granules India Trazodone Hydrochloride Tablets Ruchika Sharma9 Aug 2024 2:00 PM ISTHyderabad: Granules India Limited has announced that the US Food & Drug Administration (US FDA) has approved its Abbreviated New Drug...
Granules India Promoter sells 3.09 pecent stake for Rs 304 crore Ruchika Sharma23 May 2024 12:47 PM ISTHyderabad: Krishna Prasad Chigurupati, a promoter of Granules India, has sold a 3.09 percent stake in the company for Rs 304 crore through an...
Granules India reports 1.6 percent fall in Q4 revenue Ruchika Sharma15 May 2024 4:52 PM ISTBengaluru: Granules India reported a 1.6% decrease in revenue for the fourth quarter on Wednesday, impacted by lower paracetamol sales and price...
Granules India arm gets USFDA nod for Gout flares drug Colchicine Ruchika Sharma30 April 2024 11:30 AM ISTColchicine Capsules are indicated for prophylaxis of gout flares in adults.
Granules India gets Zero 483's from USFDA for Unit V facility in AP Ruchika Sharma13 April 2024 12:08 PM ISTTelangana: Granules India has informed in a BSE filing that the Company's Unit V facility located at Anakapally, Visakhapatnam, Andhra ...
USFDA classifies Granules Pharma facility as Voluntary Action Indicated Ruchika Sharma4 April 2024 3:00 PM ISTHyderabad: Granules India has informed in a BSE filing that the United States Food and Drug Administration (USFDA) has classified the facility of...
Granules India posts marginal rise in Q3 profit Ruchika Sharma23 Jan 2024 3:27 PM ISTBengaluru: Drug maker Granules India reported a marginal rise in third-quarter profit, helped by easing raw material costs.The company’s...
Granules India bags USFDA nod for Pantoprazole Sodium Delayed Release Tablets Ruchika Sharma13 Dec 2023 12:08 PM ISTPantoprazole Sodium Delayed-Release Tablets are indicated for short-term Treatment of Erosive Esophagitis Associated with Gastroesophageal Reflux...
Granules India subsidiary bags USFDA nod for Sildenafil for Oral Suspension Ruchika Sharma4 Dec 2023 1:30 PM ISTSildenafil for Oral Suspension is indicated for the treatment of pulmonary arterial hypertension (PAH) (World Health Organization [WHO] Group I) in...
Granules India posts 3.4 percent rise in Q2 revenue Ruchika Sharma11 Nov 2023 3:00 PM ISTBengaluru: Granules India reported a 3.4% rise in second-quarter revenue as the Paracetamol maker benefited from higher sales in North...
